The STEP trial, which evaluated semaglutide for weight management, showed that consistent weekly administration produced sustained weight loss and metabolic improvements
Consistency is often more important than the exact time of day
In metabolically healthy individuals with intact insulin signaling, leucine-stimulated mTORC1 activation promotes anabolism without impairing insulin sensitivity, whereas in individuals with established insulin resistance, the same stimulus may exacerbate S6K1-mediated IRS-1 serine phosphorylation (12)
For RA and T1D, given limited evidence from small-sample clinical studies or preclinical models, these interventions are currently in the exploratory stage and not recommended to replace conventional immunomodulators
[DOI] [PubMed] [Google Scholar] 123.Ohn J., Kim K.H., Kwon O
& Cui, X